Legal Representation
Attorney
JAMES R MEYER
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 4, 2010 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jan 4, 2010 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Jun 1, 2009 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Jun 1, 2009 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Jun 1, 2009 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Jun 1, 2009 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| May 28, 2009 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 28, 2008 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Nov 28, 2008 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Nov 28, 2008 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Nov 18, 2008 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 18, 2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 18, 2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 5, 2008 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 5, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 5, 2008 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 5, 2008 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 29, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 26, 2008 | MPMK | O | NOTICE OF PSEUDO MARK MAILED | Loading... |
| Jan 25, 2008 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Consulting and advisory services relating to diagnostic preparations and products, namely, prediction of response of individuals to pharmaceutical products and treatments for diseases and disorders of the central nervous system and psychiatric diseases and disorders; Consulting and advisory services relating to diagnostic preparations and products, namely, development, testing and efficacy of pharmaceutical preparations and products for the treatment of diseases and disorders of the central nervous system and psychiatric diseases and disorders; Consulting and advisory services relating to diagnostic preparations and products, namely, provision of goods containing reagents for use in the collection and testing of DNA, RNA and bodily tissues; Consulting and advisory services relating to diagnostic apparatus and diagnostic instruments, namely, prediction of response of individuals to pharmaceutical products and treatments for diseases and disorders of the central nervous system and psychiatric diseases and disorders; Consulting and advisory services relating to diagnostic apparatus and diagnostic instruments namely, development, testing and efficacy, of apparatus and diagnostic instruments for the treatment of diseases and disorders of the central nervous system and psychiatric diseases and disorders; Consulting and advisory services relating to diagnostic apparatus and diagnostic instruments, namely, provision of assays or assay kits for use in the collection and testing of DNA, RNA and bodily tissues; Design and control of pharmacogenetic diagnostic tests for prediction of response of individuals to pharmaceutical products and treatments for disorders of the central nervous system and psychiatric diseases and disorders; Design and control of pharmacogenetic diagnostic tests for disorders and diseases of the central nervous system and psychiatric diseases and disorders; Design and control of pharmacogenetic tests, including the devising, compiling and testing of algorithms and mathematical systems for predicting response to a pharmaceutical product based on individual genetic profile; Scientific research related to pharmacogenetics; Research and advisory services relating to pharmaceuticals
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical diagnostic services; Medical diagnostic testing relating to the human body, namely, analysis of samples to predict response of individuals to pharmaceutical products and treatments for disorders of the central nervous system and psychiatric diseases and disorders; Medical diagnostic testing relating to the human body, namely, analysis of samples to confirm diagnosis of diseases and disorders of the central nervous system and psychiatric diseases and disorders; Medical clinical services, namely, analysis of samples of DNA, RNA and bodily tissues to prescribe the prescribe the most efficient and/or efficacious pharmaceutical product to the patient; Medical clinical services, namely, the taking of samples of bodily tissues for analysis in connection with the prescription of pharmaceuticals or other medical treatment; Medical and scientific research in the nature of conducting clinical trials; Compilation of medical reports relating to prediction of response of individuals to pharmaceutical products and treatments for disorders of the central nervous system and psychiatric diseases and disorders; Compilation of medical reports relating to confirmation of diagnosis of diseases and disorders of the body, and prescription of most efficient and efficacious pharmaceutical product or method for treatment thereof; Compilation of medical reports as a resource of phenotypic and genotypic data relating to diseases and disorders of the central nervous system and psychiatric diseases and disorders; Conducting medical examinations for diagnosis and treatments of disease; Testing and profiling of pharmaceutical preparations and treatments for medical purposes; Computer aided diagnostic testing services relating to the human body
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
THERA GENETICS
Classification
International Classes
042
044